Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/dToDCfbwoceNcnzRHJGT

  ADVERTISEMENT  
October 3, 2012
Sign upForwardArchiveAdvertise
News for diabetes health professionals

  Diabetes in Focus 
  • Low eGFR increases CAD risk in type 1 diabetes
    Among type 1 diabetes patients with good glucose control, those who had lower estimated glomerular filtration rate faced a greater risk of coronary artery disease than patients with higher eGFR, a study presented at the European Association for the Study of Diabetes meeting showed. Researchers said hypertension may also predict CAD risk in patients with both high and low A1C levels. MedPage Today (free registration) (10/2) LinkedInFacebookTwitterEmail this Story
  • Fewer nocturnal hypoglycemic episodes seen with insulin degludec
    Type 2 diabetes patients who took insulin degludec or insulin glargine attained similar mean A1C and fasting plasma glucose levels at 52 weeks, a study found. However, fewer nocturnal hypoglycemic episodes were seen in the degludec-treated patients at one year, compared with those who took glargine. The results were presented at the European Association for the Study of Diabetes meeting. InternalMedicineNews.com (10/2) LinkedInFacebookTwitterEmail this Story
  • Alcohol raises A-fib risk in older diabetes patients
    Moderate alcohol consumption was associated with an increased risk of atrial fibrillation in older patients with a history of heart disease or advanced diabetes, according to a study in the Canadian Medical Association Journal. The study was based on data from more than 30,000 patients age 55 and older in 40 countries. HealthDay News (10/1) LinkedInFacebookTwitterEmail this Story
  Nutrition & Wellness 
  • More than 15 million Americans are severely obese, data show
    About 6.6% of U.S. adults, or 15.5 million, were severely obese in 2010, compared with 3.9% in 2000, researchers reported in the International Journal of Obesity. The rate of severe obesity was 50% higher in women than in men and twice as high for blacks as for Hispanics and whites. USA TODAY (10/1) LinkedInFacebookTwitterEmail this Story
  • Study: Tesamorelin boosts metabolic markers in obese
    Centrally obese patients with lower growth hormone secretion who received tesamorelin treatment attained better lean body mass, waist circumference and visceral adipose tissue levels compared with the control group, a study in The Journal of Clinical Endocrinology and Metabolism indicated. Researchers also found tesamorelin was associated with a 90% increase in insulin-like growth factor I, a 20% decrease in triglyceride rates and a 24% reduction in C-reactive protein levels. Healio/Endocrine Today (10/2) LinkedInFacebookTwitterEmail this Story
  • Study looks at weight gain over 4 years in college
    Nearly half of college freshmen examined gained 10 or more pounds by the end of their senior year, with 18% piling on 20 pounds or more, a study in Applied Physiology, Nutrition and Metabolism revealed. Easy access to all-you-can-eat cafes and fast-food establishments, late-night eating, higher alcohol intake and lower exercise levels contribute to weight gain during college, researchers noted. The Washington Post (10/1) LinkedInFacebookTwitterEmail this Story
  Practice Update 
  • Telemedicine helps boost diabetic retinopathy screening
    Adopting a telemedicine network in a primary care clinic helped boost diabetic retinopathy screening from 32% to 71% within a year, study authors wrote in the Archives of Internal Medicine. Diabetic retinopathy was more prevalent in blacks than whites, researchers noted. MedPage Today (free registration) (10/2) LinkedInFacebookTwitterEmail this Story
  Trends & Technology 
  SmartQuote 
There is nothing so agonizing to the fine skin of vanity as the application of a rough truth."
--Edward Bulwer-Lytton,
British politician, poet, playwright and novelist


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Aaron Kern (202) 407-7866
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent DiabetesPro SmartBrief Issues:   Lead Editor:  Kathryn Doherty
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information